Infection of the retina by human immunodeficiency virus type I. 1987

R J Pomerantz, and D R Kuritzkes, and S M de la Monte, and T R Rota, and A S Baker, and D Albert, and D H Bor, and E L Feldman, and R T Schooley, and M S Hirsch
Department of Medicine, Massachusetts General Hospital, Boston 02114.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D012160 Retina The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent. Ora Serrata
D012164 Retinal Diseases Diseases involving the RETINA. Disease, Retinal,Diseases, Retinal,Retinal Disease
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D015488 HIV Antigens Antigens associated with specific proteins of the human adult T-cell immunodeficiency virus (HIV); also called HTLV-III-associated and lymphadenopathy-associated virus (LAV) antigens. AIDS Antigens,HIV-Associated Antigens,HTLV-III Antigens,HTLV-III-LAV Antigens,LAV Antigens,Lymphadenopathy-Associated Antigens,T-Lymphotropic Virus Type III Antigens, Human,HIV Associated Antigens,HTLV III Antigens,HTLV III LAV Antigens,Lymphadenopathy Associated Antigens,T Lymphotropic Virus Type III Antigens, Human,Antigens, AIDS,Antigens, HIV,Antigens, HIV Associated,Antigens, HIV-Associated,Antigens, HTLV III,Antigens, HTLV-III,Antigens, HTLV-III-LAV,Antigens, LAV,Antigens, Lymphadenopathy Associated,Antigens, Lymphadenopathy-Associated,Associated Antigens, HIV,Associated Antigens, Lymphadenopathy,III Antigens, HTLV

Related Publications

R J Pomerantz, and D R Kuritzkes, and S M de la Monte, and T R Rota, and A S Baker, and D Albert, and D H Bor, and E L Feldman, and R T Schooley, and M S Hirsch
March 1992, Journal of the American Dental Association (1939),
R J Pomerantz, and D R Kuritzkes, and S M de la Monte, and T R Rota, and A S Baker, and D Albert, and D H Bor, and E L Feldman, and R T Schooley, and M S Hirsch
August 1988, Nederlands tijdschrift voor geneeskunde,
R J Pomerantz, and D R Kuritzkes, and S M de la Monte, and T R Rota, and A S Baker, and D Albert, and D H Bor, and E L Feldman, and R T Schooley, and M S Hirsch
January 1989, Revista chilena de obstetricia y ginecologia,
R J Pomerantz, and D R Kuritzkes, and S M de la Monte, and T R Rota, and A S Baker, and D Albert, and D H Bor, and E L Feldman, and R T Schooley, and M S Hirsch
April 1989, American journal of ophthalmology,
R J Pomerantz, and D R Kuritzkes, and S M de la Monte, and T R Rota, and A S Baker, and D Albert, and D H Bor, and E L Feldman, and R T Schooley, and M S Hirsch
October 1998, Disease-a-month : DM,
R J Pomerantz, and D R Kuritzkes, and S M de la Monte, and T R Rota, and A S Baker, and D Albert, and D H Bor, and E L Feldman, and R T Schooley, and M S Hirsch
December 1999, Acta medica portuguesa,
R J Pomerantz, and D R Kuritzkes, and S M de la Monte, and T R Rota, and A S Baker, and D Albert, and D H Bor, and E L Feldman, and R T Schooley, and M S Hirsch
October 2012, Retrovirology,
R J Pomerantz, and D R Kuritzkes, and S M de la Monte, and T R Rota, and A S Baker, and D Albert, and D H Bor, and E L Feldman, and R T Schooley, and M S Hirsch
December 2004, Immunology,
R J Pomerantz, and D R Kuritzkes, and S M de la Monte, and T R Rota, and A S Baker, and D Albert, and D H Bor, and E L Feldman, and R T Schooley, and M S Hirsch
September 1988, American journal of obstetrics and gynecology,
R J Pomerantz, and D R Kuritzkes, and S M de la Monte, and T R Rota, and A S Baker, and D Albert, and D H Bor, and E L Feldman, and R T Schooley, and M S Hirsch
July 1992, Science (New York, N.Y.),
Copied contents to your clipboard!